Hackensack Meridian Health’s iShares iBoxx $ Investment Grade Corporate Bond ETF LQD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-399,000
Closed -$40.9M 13
2022
Q3
$40.9M Buy
399,000
+87,000
+28% +$9.59M 5.58% 6
2022
Q2
$34.3M Buy
312,000
+87,000
+39% +$9.82M 3.82% 8
2022
Q1
$27.2M Sell
225,000
-160,000
-42% -$20M 2.84% 9
2021
Q4
$51M Buy
+385,000
New +$51.2M 4.95% 7

Other funds holding LQD

Hackensack Meridian Health's LQD Position: Q4 2022 in Review

Hackensack Meridian Health sold out of iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) in Q4 2022, closing a stake of 399,000 shares — an estimated $40.9M sold.

Hackensack Meridian Health first reported a position in LQD in Q4 2021 and held it in 4 quarters. The position peaked at $51M in Q4 2021. 1,018 funds tracked by Wall St. Rank hold LQD as of Q4 2022.

  • Hackensack Meridian Health reported no remaining iShares iBoxx $ Investment Grade Corporate Bond ETF position as of Q4 2022 after selling out during the quarter.
  • Hackensack Meridian Health sold 399,000 iShares iBoxx $ Investment Grade Corporate Bond ETF shares in Q4 2022, an estimated $40.9M.
  • Hackensack Meridian Health first reported a position in iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2021 and held it in 4 quarters.
  • Hackensack Meridian Health's iShares iBoxx $ Investment Grade Corporate Bond ETF position peaked at $51M in Q4 2021.
  • 1,018 funds tracked by Wall St. Rank held iShares iBoxx $ Investment Grade Corporate Bond ETF as of Q4 2022.

Based on Hackensack Meridian Health's 13F filing for Q4 2022, filed 7 Feb 2023.